Strengthening the cornea to help protect your vision
Keratoconus is a condition where the cornea, the clear front window of the eye, becomes thinner and gradually changes shape.
Instead of staying round and regular, the cornea can start to bulge forward into a cone-like shape. This can cause blurred vision, increasing astigmatism, glare, ghosting, halos, and difficulty seeing clearly even with glasses.
UV collagen cross-linking (UVCXL), also called corneal collagen cross-linking or CXL, is a treatment designed to strengthen the cornea and slow or stop the progression of keratoconus.
It does not replace glasses or contact lenses. Its main job is to stabilise the cornea and help protect the vision you have.
What is UV collagen cross-linking?
Corneal collagen cross-linking uses two things:
- Riboflavin eye drops, which are vitamin B2 drops
- Controlled ultraviolet A light, applied to the cornea
Together, these create new bonds between the collagen fibres in the cornea. This results in the cornea becoming stronger and less likely to continue changing shape.
Cross-linking is widely used for progressive keratoconus and post-laser corneal ectasia. The aim is to reduce the risk of further deterioration over time.
Who may need collagen cross-linking?
You may be suitable for cross-linking if you have keratoconus that is getting worse.
This may show up as:
- Increasing astigmatism
- Frequent changes in glasses prescription
- Worsening corneal scans
- Increasing corneal steepness
- Reduced quality of vision
- Difficulty with contact lenses
- Keratoconus diagnosed at a younger age, where progression can be more likely
The decision is not made from one number alone. I look carefully at your corneal shape, corneal thickness, prescription, age, vision, symptoms, and whether there is evidence the condition is changing. Stopping eye rubbing is a mainstay of treatment, and will decrease the risk of progression of your keratoconus and increase the success of any treatment
What happens during the procedure?
Cross-linking is usually performed as a day procedure.
The eye is numbed with anaesthetic drops. In the most commonly performed technique, the thin surface layer of the cornea is gently removed so the riboflavin drops can soak into the corneal tissue properly.
The riboflavin drops are then applied frequently a period of time, usually 30 minutes. Once the cornea has absorbed enough riboflavin, a carefully controlled UV light is shone onto the cornea.
At the end of the procedure, a soft bandage contact lens is placed on the eye to help the surface heal.
You go home the same day.
What should I expect afterwards?
The first few days can be uncomfortable. The eye may feel gritty, watery, light sensitive, or sore while the surface layer heals.
Most people need some time off work or study, especially in the first few days. Vision is usually blurry at first and then gradually improves as the cornea heals.
It is very normal for the vision to fluctuate in the early recovery period.
Cross-linking is not a quick vision-fixing procedure. It is a stabilising treatment. The benefit is measured over time by watching whether the cornea remains stable on serial corneal scans.
Will cross-linking improve my vision?
Sometimes vision improves slightly after cross-linking, but that is not the main goal.
The main goal is to stop the keratoconus from getting worse, and halt progression.
Many patients still need glasses, contact lenses, or specialty contact lenses after cross-linking to achieve their clearest vision.
Corneal cross-linking strenthens the cornea, but glasses, contact lenses, or further surgical intervention such as ICL surgery usually refine the vision.
Why early diagnosis matters
Keratoconus can progress more quickly in younger patients, and once the cornea has become very thin or very steep, treatment options can become more limited.
This is why early detection matters.
If keratoconus is found early and shown to be progressing, cross-linking may help preserve vision and reduce the risk of needing more invasive surgery later. Studies and clinical guidance support cross-linking as a treatment for progressive keratoconus.
Is cross-linking safe?
Cross-linking is a well-established treatment, but like any eye procedure, it has risks.
Possible risks include:
- Pain or discomfort during healing
- Infection
- Delayed surface healing
- Corneal haze
- Temporary worsening or fluctuation of vision
- Dryness or irritation
- Rare loss of vision
These risks are uncommon, but they are important to understand. Your suitability depends on the health, shape, and thickness of your cornea.
My approach
Keratoconus is not just a scan diagnosis.
It affects real people, often young people, who may be trying to study, work, drive, play sport, or function without constantly changing glasses or struggling with night vision.
My goal is to identify progression early, explain the options clearly, and recommend treatment when it is likely to protect your long-term vision.
Not every patient with keratoconus needs immediate cross-linking. But if the cornea is changing, waiting too long can matter.
Frequently Asked Questions
What is keratoconus?
Keratoconus is a condition where the cornea becomes thinner and more irregular in shape. This can distort the way light enters the eye, causing blurred or distorted vision.
What does collagen cross-linking do?
Collagen cross-linking strengthens the cornea by using riboflavin drops and UV light to create extra bonds between collagen fibres. The aim is to slow or stop further progression of keratoconus.
Does cross-linking cure keratoconus?
No. Cross-linking does not cure keratoconus or make the cornea perfectly normal again. It is designed to stabilise the cornea and reduce the risk of further progression.
Will I still need glasses or contact lenses after cross-linking?
Often, yes. Cross-linking is mainly a stabilising treatment. Glasses, soft contact lenses, rigid contact lenses, scleral lenses, or other treatments involving elective surgical intervention such as ICL surgery may still be needed to improve the clarity of vision.
Is cross-linking painful?
The procedure itself is usually not painful because anaesthetic drops are used. The eye can be sore, gritty, watery, and light sensitive for the first few days afterwards while the surface heals.
How long does recovery take?
The surface of the eye usually heals over several days, but vision can fluctuate for weeks. The cornea continues to settle over months, and follow-up scans are used to monitor stability. Usually the final outcome after cross linking is not determined for 6 to 12 months.
Can both eyes be treated on the same day?
Often, one eye is treated at a time so healing and recovery can be monitored carefully.
What age is best for cross-linking?
There is no single best age. The key issue is whether the keratoconus is progressing or whether the patient is at high risk of progression. Younger patients often need closer monitoring because keratoconus can progress more quickly in this group.
What happens if keratoconus is not treated?
If keratoconus continues to progress, vision may worsen, glasses may become less effective, and contact lenses may become harder to fit. In advanced cases, corneal transplant surgery may be needed.
Can I have laser eye surgery if I have keratoconus?
Usually, laser vision correction is not suitable for patients with keratoconus because laser reshapes and removes tissue from the cornea. In a cornea that is already weakened or irregular, this can be unsafe. A detailed corneal assessment is essential.
Is cross-linking the same as laser eye surgery?
No. Laser eye surgery reshapes the cornea to reduce dependence on glasses or contact lenses. Cross-linking strengthens the cornea to reduce progression of keratoconus. They are completely different procedures.
How do I know if my keratoconus is getting worse?
Progression is assessed by comparing scans and measurements over time. This may include corneal topography or tomography, prescription changes, corneal thickness, and vision changes.
Do I need treatment straight away?
Not always. Some patients need monitoring first. But if there is evidence of progression, cross-linking may be recommended to help protect the cornea before the disease becomes more advanced.
What is the goal of treatment?
The goal is stability. The best outcome is often that the cornea stops changing, your scans remain stable, and your risk of future vision loss is reduced.